Several early studies of alterations at the FHIT locus in breast cancer reported reduced expression of Fhit in ∼40–60% of mammary carcinomas and an elevated frequency of loss in BRCA2-linked breast carcinomas (Huebner and Croce, 2001). This evidence concerns the gene FHIT and breast carcinoma.